chr7-35248766-G-C
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_001077653.2(TBX20):c.456C>G(p.Ile152Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000384 in 1,614,028 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. I152I) has been classified as Likely benign.
Frequency
Consequence
NM_001077653.2 missense
Scores
Clinical Significance
Conservation
Publications
- atrial septal defect 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152154Hom.:  0  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.0000199  AC: 5AN: 251494 AF XY:  0.0000221   show subpopulations 
GnomAD4 exome  AF:  0.0000410  AC: 60AN: 1461874Hom.:  0  Cov.: 37 AF XY:  0.0000358  AC XY: 26AN XY: 727242 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152154Hom.:  0  Cov.: 31 AF XY:  0.0000135  AC XY: 1AN XY: 74326 show subpopulations 
ClinVar
Submissions by phenotype
Atrial septal defect 4    Pathogenic:1Uncertain:2 
- -
This variant was classified as: Uncertain significance. The available evidence favors the pathogenic nature of this variant, however the currently available data is insufficient to conclusively support its pathogenic nature. Thus this variant is classified as Uncertain significance - favor pathogenic. The following ACMG criteria were applied in classifying this variant: PS3_SUP,PS4_SUP,PP3. -
- -
not provided    Uncertain:2 
Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17668378, 31589614) -
This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 152 of the TBX20 protein (p.Ile152Met). This variant is present in population databases (rs137852954, gnomAD 0.004%). This missense change has been observed in individual(s) with congenital heart disease and/or dilated cardiomyopathy (PMID: 17668378, 34328347, 36178741). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4632). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt TBX20 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects TBX20 function (PMID: 17668378, 19762328). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype    Uncertain:1 
The p.I152M variant (also known as c.456C>G), located in coding exon 3 of the TBX20 gene, results from a C to G substitution at nucleotide position 456. The isoleucine at codon 152 is replaced by methionine, an amino acid with highly similar properties. This variant was detected in a family with a history of congenital heart defects, including the proband with an atrial septal defect, her mother with a large patent foramen ovale, and her maternal grandmother with a small ventricular septal defect (Kirk EP et al. Am J Hum Genet, 2007 Aug;81:280-91). This variant was also detected in a pediatric dilated cardiomyopathy cohort; however, the affected case reportedly had confirmed GM1 gangliosidosis and was also homozygous for a GLB1 mutation (Herkert JC et al. Genet Med, 2018 11;20:1374-1386). Limited functional studies suggested reduced function, but the clinical impact is uncertain (Kirk EP et al. Am J Hum Genet, 2007 Aug;81:280-91; Posch MG et al. J Med Genet, 2010 Apr;47:230-5). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at